Verde Science, Inc. (OTCPK: VRCI)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Verde Science, Inc. (OTCPK: VRCI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.00 and employs 1 people.
trading between 0.00 and 0.00.
Tweenvest scores Verde Science, Inc. across four factors: quality 26/100. Its strongest factor is quality.
VRCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 30.31
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.87M
- Employees
- 1
- Next earnings
- —
About Verde Science, Inc.
Verde Science, Inc., a pharmaceutical research and development enterprise, is dedicated to advancing a diverse array of prescription medications derived from cannabinoids, intended for the treatment of numerous health conditions. The company, which initially operated as Rango Energy, Inc., officially transitioned to the name Verde Science, Inc. in May 2014. Established in 2007, the company maintains its operational headquarters in Dallas, Texas.
- ISIN
- US92337L2034
- Founded
- 2007
- Listed since
- Feb 10, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.33 | +0.15% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.49 | +0.46% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.23 | +0.45% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.